Pulmonary Function Test: Nursing Guide
Pulmonary function testing — most often spirometry — measures how much air the lungs hold and how fast it moves during forced breathing. Nurses verify orders and bronchodilator holds, coach valid effort, document pre- and post-bronchodilator timing, and escalate when acute dyspnea or hypoxemia should delay testing or when results diverge sharply from symptoms.
Contents
Quick Facts
Key Takeaway
Spirometry guides diagnosis and severity only when effort is valid, bronchodilator timing matches the clinical question, and results are read with symptoms — not as a single number alone.
Procedure Safety Checklist
Pre-procedure safety checks — confirm each item before the patient leaves the ward or clinic.
Correct patient, order (baseline vs post-bronchodilator), and indication
Recent bronchodilator, smoking, and large-meal timing documented per protocol
Acute dyspnea, chest pain, hemoptysis, or unstable vitals reviewed before forced manoeuvres
Ability to stand or sit upright, seal mouthpiece, and perform forced expiration
Baseline symptoms, SpO₂, and current inhaler or nebulizer use on MAR
Contraindications to forced expiration cleared with prescriber when present
Transport, interpreter, and anxiety or pain needs arranged for outpatient visits
Plan for post-test monitoring when bronchodilator will be given in the lab
Not required for standard spirometry — coach effort; pause if acute distress develops
What is Pulmonary Function Test?
Pulmonary Function Test is a group of breathing tests — most commonly spirometry — that measure lung volumes and airflow during quiet and forced breathing. Key indices include forced expiratory volume in one second (FEV₁), forced vital capacity (FVC), and the FEV₁/FVC ratio. Testing is performed in pulmonary function laboratories or respiratory clinics by trained technologists; nurses coordinate preparation, safety screening, transport, and clinical follow-up on results.
Overview
Nurses in primary care, pulmonary clinics, and inpatient units refer patients for pulmonary function testing when persistent cough, shortness of breath, or wheezing need objective airflow measurement. The American Thoracic Society and European Respiratory Society describe spirometry as the principal test for detecting airflow limitation and bronchodilator responsiveness. Ward nurses do not operate the spirometer but are essential for medicine holds, symptom surveillance, and communicating results with the clinical picture.
Formal spirometry differs from bedside peak expiratory flow monitoring and from post-operative incentive spirometry — it supports diagnosis and severity grading for asthma and chronic obstructive pulmonary disease when paired with clinical assessment and, when indicated, chest imaging.
Before pulmonary function testing, confirm bronchodilator hold instructions and whether the order is baseline, post-bronchodilator, or both. After testing, integrate FEV₁, FVC, and FEV₁/FVC with symptoms and SpO₂ — and escalate when the patient develops acute respiratory distress during or after manoeuvres.
Spirometry Effort, Bronchodilator Holds, and Acute Dyspnea Safety
Invalid spirometry harms patients when submaximal effort is read as severe obstruction, when recent bronchodilator use masks baseline disease, or when acute hypoxemia is ignored because testing was scheduled. Nurses protect validity with medicine timing checks, symptom monitoring, and prescriber communication before and after the laboratory visit.
- Recent rescue bronchodilator before baseline spirometry without prescriber or lab notification
- Hypoxemia, chest pain, or syncope during forced expiration
- Severe dyspnea with poor bronchodilator response despite abnormal spirometry
- Normal spirometry dismissed while symptoms and SpO₂ worsen
Document: bronchodilator hold compliance, FEV₁/FVC indices, symptoms, SpO₂, staff notified, and prescriber communication.
What Pulmonary Function Testing Can and Cannot Tell You
This test can help identify:
- Airflow limitation when effort is valid (reduced FEV₁/FVC)
- Significant bronchodilator responsiveness on pre/post testing
- Restrictive or mixed patterns when lung volumes are included
- Serial change in FEV₁ for monitoring asthma or COPD control
This test cannot:
- Diagnose asthma or COPD without clinical assessment and guideline context
- Replace chest imaging for parenchymal disease or pulmonary embolism evaluation
- Override acute respiratory distress — treat first when unstable
- Remain valid after unrecorded bronchodilator use or consistently poor effort
Obstructive, Restrictive, and Bronchodilator Response Patterns
Nurses use pattern labels to anticipate prescriber questions and patient teaching — always confirm effort quality and reference ranges on the laboratory report.
| Pattern | Typical spirometry features | Nursing focus |
|---|---|---|
| Obstructive | Reduced FEV₁/FVC with low FEV₁ — asthma or COPD when clinical picture fits | Review inhaler adherence; monitor symptoms and SpO₂; escalate acute flares |
| Restrictive | Reduced FVC with relatively preserved FEV₁/FVC — may need full lung volumes | Correlate with chest wall, neuromuscular, or parenchymal workup per prescriber |
| Significant BD response | FEV₁ increase ≥12% and ≥200 mL after bronchodilator (common ATS/ERS threshold) | Document timing; communicate to prescriber for therapy adjustment |
| Non-reversible obstruction | Low FEV₁/FVC with minimal post-BD change | Support COPD pathways, smoking cessation, and follow-up planning |
Medicine Holds, Technique, and Symptom Mismatch Traps at the Bedside
| Bedside point | Nursing note |
|---|---|
| Hold window truth | Ask what inhalers the patient actually used — do not rely on written instructions alone |
| Symptoms trump numbers | Escalate distress even when a single blow looks acceptable |
| Pre/post sequence | Document whether tracing is baseline or after inhaled bronchodilator in lab |
| NCLEX trap | Do not withhold rescue therapy during active wheeze to preserve test validity |
| Evaluate outcomes | After in-lab bronchodilator, repeat symptoms and SpO₂ — did wheeze improve with FEV₁? |
| Incentive spirometry | Post-op deep-breathing device is not diagnostic spirometry — avoid confusing teaching |
PFT Pathway Across Clinic, PFT Lab, and Inpatient Settings
Diagnostic safety badge: Outpatient pulmonary function testing — invalid medicine timing or poor effort can misguide therapy; acute dyspnea during testing upgrades to urgent respiratory pathway.
PFT visit protocol
- Identity + order + hold instructions verified
- Baseline symptoms and SpO₂ documented
- Communicate hold deviations to PFT staff and prescriber
- Support effort coaching and monitor during manoeuvres
- Review report, notify prescriber, and teach follow-up plan
Critical teach-back questions
- “Which inhalers should you skip before spirometry and for how long?”
- “What symptoms during the test should you report immediately?”
- “What does a significant improvement after bronchodilator mean for your action plan?”
Care coordination: primary prescriber, pulmonary function laboratory, respiratory therapy, asthma or COPD education services, and emergency pathways when acute distress develops.
Why Pulmonary Function Test is Ordered
Pulmonary function testing is ordered when clinicians need objective measurement of airflow limitation, lung volumes, or bronchodilator response beyond physical examination alone.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Suspected asthma or COPD | Is there airflow limitation and is it reversible with bronchodilator? | Supports diagnosis and severity assessment per asthma and COPD guidelines when symptoms such as wheeze or dyspnea persist — spirometry should be interpreted with clinical findings, not alone. |
| Monitoring disease control or treatment response | Has FEV₁ or flow improved after controller or bronchodilator therapy? | Serial spirometry tracks obstructive trends; nurses document medicine timing so comparisons remain valid. |
| Pre-operative or occupational respiratory assessment | What is baseline pulmonary reserve before surgery or exposure review? | Identifies patients who may need higher-level respiratory support planning — interpretation follows surgical or occupational medicine protocols. |
| Unexplained dyspnea or abnormal imaging | Is the pattern obstructive, restrictive, or mixed? | Pairs with chest imaging and respiratory assessment when parenchymal or airway disease remains unclear. |
Contraindications and Precautions
Spirometry is generally safe, but forced expiration should be deferred or modified when risks outweigh benefit — for example recent myocardial infarction, unstable angina, pneumothorax, hemoptysis of unknown cause, or inability to perform manoeuvres safely. Acute severe respiratory distress may require treatment before elective testing.
- Acute severe dyspnea, hypoxemia, or altered mental status — treat and stabilize per protocol before forced manoeuvres.
- Recent thoracic or abdominal surgery, eye surgery, or known pneumothorax without prescriber clearance.
- Active hemoptysis or chest pain triggered by forced expiration — notify prescriber before continuing.
- Recent short-acting bronchodilator use when baseline spirometry is ordered — may mask obstruction.
- Smoking or large meal shortly before testing — may affect effort or bronchial tone per institutional protocol.
- Poor lip seal, early termination, or coughing into mouthpiece — invalidates FEV₁ and FVC.
- SpO₂ below institutional threshold or rapidly worsening work of breathing during testing — stop manoeuvres and escalate per respiratory emergency protocol.
- Chest pain, dizziness, or syncope during forced expiration — notify prescriber and PFT staff immediately.
- Markedly abnormal spirometry with severe symptoms but no follow-up plan — notify prescriber for same-day review.
Patient Preparation
Preparation focuses on medicine and smoking holds, valid effort coaching, and matching the order to baseline versus bronchodilator-response testing.
Pre-test checksReview short- and long-acting bronchodilators, inhaled corticosteroids, and systemic steroids on the MAR. Do not withhold prescribed rescue therapy when the patient is in acute distress to obtain a baseline tracing — clarify timing with prescriber or pulmonary function staff. Document last doses of albuterol and other inhalers.
Where the test is performed
This page is a Tests & Diagnostics guide for Pulmonary Function Test. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Pulmonary Function Test (spirometry and related lung-volume testing) is performed in pulmonary function laboratories or respiratory clinics by trained pulmonary function technologists or respiratory therapists. Ward and clinic nurses focus on order verification, bronchodilator and smoking holds that affect baseline validity, transport and symptom monitoring, pre- and post-bronchodilator timing documentation, and acting on obstructive or restrictive patterns with symptoms — not mouthpiece technique or spirometer calibration.
Use the preparation, results, and nursing responsibility sections below for safety checks, interpretation, escalation, and documentation — not equipment operation or departmental imaging protocols.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
Spirometry reports FEV₁, FVC, FEV₁/FVC, and often percent predicted values. Nurses support patients in understanding that effort quality and bronchodilator timing affect validity — and that patterns are interpreted with symptoms, examination, and trends.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Within reference interval | FEV₁ and FVC within predicted reference limits with FEV₁/FVC above the lower limit of normal for the laboratory | No significant airflow limitation on this valid effort — does not exclude disease if symptoms persist | Document; correlate with symptoms; repeat or add testing if clinical suspicion remains |
| Borderline / near reference limit | Values near lower limit of normal or mild reduction in FEV₁/FVC — effort and timing must be verified | May represent early obstruction or submaximal effort — interpret with repeat testing or clinical follow-up per prescriber | Confirm medicine holds and technique; notify prescriber when symptoms outpace mild numeric changes |
| High / above reference interval | Not applicable in the chemistry sense — spirometry uses ratios and percent predicted, not elevated above-normal chemistry patterns | Not applicable for standard spirometry interpretation | Focus on obstructive, restrictive, or mixed low-flow patterns |
| Low / below reference interval | Reduced FEV₁/FVC suggesting obstruction, or reduced FVC with relatively preserved ratio suggesting restriction — per reporting laboratory | Airflow limitation or reduced lung volumes — severity graded with percent predicted and clinical context | Notify prescriber; reinforce controller or rescue plans; escalate if symptoms and SpO₂ are worsening |
Acute Respiratory Events During or After Spirometry
Spirometry does not use laboratory critical-value thresholds like chemistry panels. Urgent nursing action depends on clinical deterioration during forced manoeuvres or when severely abnormal results accompany unstable symptoms — always pair numbers with assessment and local escalation policy.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Hypoxemia or severe dyspnea during testing | Falling SpO₂, inability to speak in full sentences, or accessory muscle use | Stop manoeuvres; apply ordered oxygen; escalate per respiratory emergency protocol |
| Chest pain or syncope with forced expiration | New chest pain, presyncope, or hemodynamic change during blows | Terminate testing; notify prescriber and PFT staff; monitor until stable per protocol |
| Severely reduced FEV₁ with acute symptoms post-test | Very low percent predicted FEV₁ with wheeze, hypoxemia, or poor bronchodilator response | Notify prescriber; administer ordered rescue therapy; consider arterial blood gas or urgent review per pathway |
Stop pulmonary function testing and escalate according to facility policy when the patient develops hypoxemia, chest pain, syncope, or hemoptysis during manoeuvres, or when severe symptoms persist despite bronchodilator therapy — even if numeric results are not yet finalized.
Factors Affecting Results
Spirometry validity depends on effort, bronchodilator timing, and patient factors that affect airway calibre.
- Submaximal effort mimicking obstruction — low FEV₁ with normal FEV₁/FVC on repeat quality blow
- Recent bronchodilator before baseline study — falsely improved or normalized flows
- Single normal spirometry during symptom-free interval while disease is intermittent
- Poor technique or early termination — falsely low volumes
- Testing during acute infection without clinical correlation — may not reflect baseline control
- Assuming normal peak flow or symptoms rule out obstruction when spirometry was never performed
- Bronchodilator not held for required interval before baseline test
- Recent smoking or respiratory infection
- Pain, anxiety, or language barrier reducing effort without coaching
Spirometry primarily measures airflow and some volumes — it does not diagnose asthma or COPD alone, does not replace imaging for parenchymal disease, and may be normal between exacerbations. Reference equations and bronchodilator response thresholds vary by laboratory and guideline. Turnaround and screening rules vary by institution; follow local institutional policy for universal numeric cutoffs across all ages and devices — follow the reporting laboratory and local policy.
Nursing Responsibilities
Nursing care centers on valid preparation, symptom monitoring during testing, result communication, and escalation when clinical status diverges from numeric reports.
Before the TestDocumentation
Documentation should link preparation, effort quality, and clinical status to reported indices for safe handoffs.
“Outpatient PFT for persistent wheeze. Pre-test: albuterol MDI last used 45 minutes ago despite 4-hour hold order — pulmonary function staff notified. Baseline FEV₁ 1.65 L (62% predicted), FVC 2.70 L, FEV₁/FVC 0.61. Post-bronchodilator FEV₁ 1.88 L (+14%, +230 mL). Patient reports improved wheeze; SpO₂ 96% room air. Prescriber notified of obstructive pattern with significant bronchodilator response; controller therapy review ordered.”
- Order type, medicine holds, and any hold deviations communicated
- FEV₁, FVC, FEV₁/FVC, and percent predicted with pre/post timing
- Symptoms, SpO₂, and effort or coaching notes
- Bronchodilator given in lab and repeat measurement times
- Prescriber notification and orders received
- Patient teaching on inhaler use and follow-up plan
Patient and Family Education
Use plain language; explain that the test measures how fast and how much air they can blow out, not whether they are breathing normally at rest.
Pulmonary Function Test NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Pulmonary Function Test safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: Complete spirometry with pre- and post-bronchodilator sequence — persistent wheeze
- Indication: Adult with suspected asthma; baseline airflow before controller adjustment
- Timing: Scheduled morning PFT; post-bronchodilator repeat due after inhaled albuterol in lab
- Related orders: Hold albuterol 4 hours before baseline; continue fluticasone; SpO₂ on arrival
- Result: Baseline FEV₁ 1.72 L (64% predicted), FVC 2.85 L, FEV₁/FVC 0.60; post-BD FEV₁ 1.98 L (+15%, +260 mL)
- Trend / prior value: Prior clinic peak flow 320 L/min (80% personal best) one week ago; today increased wheeze in waiting area
- Pending tests: Formal printed report and prescriber review of controller plan
- Vital signs: T 37.0 °C, HR 96/min, RR 22, BP 128/76, SpO₂ 93% on room air
- Symptoms: Expiratory wheeze, chest tightness; speaking in full sentences
- Focused assessment: Prolonged expiratory phase; mild accessory muscle use; effort on first blow appeared submaximal
- Preparation notes: Patient reports albuterol MDI two puffs 35 minutes ago despite 4-hour hold instruction
- Collection events: Technologist repeated baseline attempts with coaching; third trace acceptable per lab
- Teaching gaps / safety concerns: Recent rescue bronchodilator may affect baseline; SpO₂ 93% with wheeze — prescriber not yet notified of prep variance
Answer key & rationale
Frequently Asked Questions
FAQ
What does a pulmonary function test measure?
Most often spirometry measures how much air you can blow out in one second (FEV₁), total forced volume (FVC), and the ratio between them. standard clinical references and NHLBI materials describe these tests as ways to assess how well the lungs move air.
Do patients need to stop inhalers before spirometry?
Many protocols require withholding short-acting bronchodilators for several hours and long-acting agents longer before baseline testing. Always follow the ordering clinician and pulmonary function laboratory instructions — do not stop rescue therapy during acute distress without prescriber guidance.
What is an obstructive pattern on spirometry?
An obstructive pattern typically shows reduced FEV₁/FVC with low FEV₁ — consistent with airflow limitation such as asthma or COPD when effort is valid. Final diagnosis requires clinical assessment and guideline-based interpretation, not spirometry alone.
What counts as a significant bronchodilator response?
ATS/ERS bronchodilator testing guidance commonly defines significant response as an increase in FEV₁ of at least 12% and at least 200 mL from baseline after bronchodilator. Laboratory and institutional reporting may vary — use the reporting facility’s criteria.
When should nurses delay or stop pulmonary function testing?
Defer or stop when the patient has acute severe dyspnea, significant hypoxemia, chest pain, hemoptysis, recent pneumothorax, or other contraindications to forced expiration — escalate according to facility policy.
Does normal spirometry rule out asthma?
No. Spirometry can be normal between exacerbations or if bronchodilators were not held appropriately. national clinical guidelines asthma guidance emphasizes clinical assessment and may recommend repeat or further testing when suspicion remains.
How is pulmonary function testing different from peak flow monitoring?
Peak flow is a simple bedside measure of maximum expiratory speed; formal spirometry in a pulmonary function laboratory provides FEV₁, FVC, ratios, and bronchodilator response for diagnosis and severity grading. They complement each other but are not interchangeable.
References
References
-
American Thoracic Society. Pulmonary Function Tests — Patient Information Series. ATS.https://www.thoracic.org/statements/patient-information-series/pf-tests.php
-
MedlinePlus Medical Encyclopedia. Pulmonary function tests. U.S. National Library of Medicine.https://medlineplus.gov/lab-tests/pulmonary-function-tests/
-
National Heart, Lung, and Blood Institute. Lung Tests. NIH.https://www.nhlbi.nih.gov/health/lung-tests
-
National Institute for Health and Care Excellence. Asthma: diagnosis, monitoring and chronic asthma management. NICE guideline NG80.https://www.nice.org.uk/guidance/ng80
-
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of COPD. GOLD.https://goldcopd.org/
-
Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease (COPD). CDC.https://www.cdc.gov/copd/
-
National Health Service. Lung function tests. NHS.uk.https://www.nhs.uk/tests-and-treatments/lung-function-tests/
-
American Lung Association. Pulmonary Function Tests.https://www.lung.org/lung-health-diseases/lung-procedures-and-tests/lung-function-tests/pulmonary-function-tests
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Pulmonary Function Test.
Policies: Medical Review Process · Editorial Policy · Correction Policy